Atrial fibrillation control and cardioversion.

RA Harrison; G. Liratsopulos

doi:10.1016/S0140-6736(00)04275-6

Atrial fibrillation control and cardioversion.

RA Harrison, G. Liratsopulos

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Lancet
Volume	357( 9262)
DOIs	https://doi.org/10.1016/S0140-6736(00)04275-6
Publication status	Published - 7 Apr 2001

Keywords

therapeutic use: Amiodarone
therapeutic use: Anti-Arrhythmia Agents
drug therapy: Atrial Fibrillation
therapeutic use: Diltiazem
Electric Countershock
Humans
Treatment Outcome

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(00)04275-6

Cite this

@article{b8dc800a667143958f6fd0fdc12e0d08,

title = "Atrial fibrillation control and cardioversion.",

keywords = "therapeutic use: Amiodarone, therapeutic use: Anti-Arrhythmia Agents, drug therapy: Atrial Fibrillation, therapeutic use: Diltiazem, Electric Countershock, Humans, Treatment Outcome",

author = "RA Harrison and G. Liratsopulos",

year = "2001",

month = apr,

day = "7",

doi = "10.1016/S0140-6736(00)04275-6",

language = "English",

volume = "357( 9262)",

journal = "Lancet",

issn = "1474-547X",

publisher = "The Lancet",

}

TY - JOUR

T1 - Atrial fibrillation control and cardioversion.

AU - Harrison, RA

AU - Liratsopulos, G.

PY - 2001/4/7

Y1 - 2001/4/7

KW - therapeutic use: Amiodarone

KW - therapeutic use: Anti-Arrhythmia Agents

KW - drug therapy: Atrial Fibrillation

KW - therapeutic use: Diltiazem

KW - Electric Countershock

KW - Humans

KW - Treatment Outcome

U2 - 10.1016/S0140-6736(00)04275-6

DO - 10.1016/S0140-6736(00)04275-6

M3 - Article

SN - 1474-547X

VL - 357( 9262)

JO - Lancet

JF - Lancet

ER -